Published 15:52 IST, August 30th 2020

COVID-19: Australia to provide $1.48 million worth of PPE to Indonesian military

The Australian government said that it will provide 2 million Australian dollars, that is, $1.48 million worth of PPE to the Indonesian military.

Reported by: Akanksha Arora
Follow: Google News Icon
  • share
null | Image: self
Advertisement

Australian government said that it will provide Personal Protective Equipment (PPE) worth of 2 million Australian dollars, that is $1.48 million, to Indonesian military in order to help m in ir battle against vel coronavirus. According to reports by AP, Australian Air Force will be delivering equipments like surgical gloves, gowns, masks and rmometers to Indonesia. Reports suggest that Indonesia has reported a total number of 169,195 cases as of w with 7,261 casualties. 

Read: Indonesia To Begin Human Trials Of COVID-19 Vaccine By China's Sivac Biotech

Advertisement

Indonesia fights against vel coronavirus 

Indonesia's state-owned pharmaceutical company Bio Farma and China's Sivac have already started with Phase III of clinical trials for COVID-19 vaccine CoronaVac. However, Indonesian government had anunced partnership between Bio Farma and Chinese company Sivac BioTech early in month of July. As part of deal, Indonesia recruited 1,620 volunteers for trial. first 20 were injected with candidate vaccine in Bandung and West Java province, while more followed suit.

Read: India Co-sponsors Indonesia's Women In Peacekeeping Resolution At United Nations

Advertisement

Bio Farma currently has a production capability of 100 million vaccine doses. company is building a new facility, expected to be completed in December, that will increase capacity to 250 million doses. Use of vaccine will be prioritized for Indonesia, world’s fourth most populated country, Bio Farma CEO Honesti Basyir said. COVID-19 experimental vaccine used in last st trials has been developed by Chinese drug maker Sivac Biotech Ltd. In collaboration with a team of Indonesian scientists and researchers, as well as Indonesian state-owned drug maker PT Bio Farma, a professor at Padjadjaran Public University in West Java provincial capital of Bandung, Kusnandi Rusmil reportedly said. He added that vaccine candidates passed through Phase I and Phase II clinical trials successfully with promising results. vaccine, in those trials, is proven “safe”, he added.  

Read: Indonesia: Police To Launch Probe Into Fire At Attorney General’s Office Building

Advertisement

Also Read: Indonesia Sinabung Volca Spews New Burst Of Hot Ash

(Im Credits: AP)

15:52 IST, August 30th 2020